# Assessment of Novel Pneumococcal Conjugate Vaccination Scheduled in UK Infants

> **NCT02918708** · PHASE4 · WITHDRAWN · sponsor: **Public Health England**

## Conditions studied

- Vaccination
- Immunization

## Interventions

- **BIOLOGICAL:** Synflorix
- **BIOLOGICAL:** Prevenar13

## Key facts

- **NCT ID:** NCT02918708
- **Lead sponsor:** Public Health England
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** 2017-01-01
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** funding channel amended by UK department of health
- **Last updated:** 2019-08-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02918708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02918708, "Assessment of Novel Pneumococcal Conjugate Vaccination Scheduled in UK Infants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02918708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*